Division Focus: Pediatric Nephrology

Division Focus: Pediatric Nephrology click to enlarge Pediatric Visits/Year (n=2077)

Division of Pediatric Nephrology provides comprehensive, state-of-the-art care to children with a wide variety of problems including hematuria (blood in the urine), proteinuria (protein in the urine), hypertension (high blood pressure), acid-base and salt-water disturbances, acute and chronic kidney failure, and other diseases of the kidneys. Our providers see more than 2,000 pediatric outpatient visits annually at the UNC Ambulatory Care Center. 


Our goals are to

  • Provide high-quality, collaborative, multi-disciplinary care to infants, children, adolescents and emerging adults with all forms of kidney disease and hypertension;
  • Actively participate in clinical, translational, and laboratory research; and
  • Educate patients and their families, medical students, residents, fellows, and faculty peers.


  • Percutaneous renal biopsy
  • Peritoneal dialysis
  • Ambulatory peritoneal dialysis
  • Continuous cycling peritoneal dialysis
  • Hemodialysis
  • Continuous renal replacement therapy
  • 24-hour ambulatory blood pressure monitoring

Innovation & Research

Dr. Ferris with patient.
Dr. Ferris with patient.
The UNC Self-management and Transition Program (STARx) was created in 2006 under the leadership of Maria Ferris, MD, PhD, and has currently enrolled over 1000 adolescents and young adults with chronic health conditions across multiple subspecialties. In 2009, Dr. Ferris co-founded the International Health Care Transition Research Consortium to promote evidence-based, literacy-appropriate, and culturally sensitive health care transition programs.The UNC Pediatric Nephrology Group has fostered a national reputation for excellence in promoting the inclusion of children large multi-center trials an effort to improve quality care through research and evidence-based medicine. Keisha Gibson, MD, MPH, is currently enrolling pediatric patients with glomerular disorders such as lupus nephitis, minimal change disease, and focal segmental glomerulosclerosis (FSGS) in observational and interventional clinical trials.

Filed under: